Android app on Google Play

Hologic (HOLX) Sum-of-Parts Worth $29/Sh - Needham & Company

November 26, 2013 10:24 AM EST Send to a Friend
Get Alerts HOLX Hot Sheet
Price: $25.30 +1.73%

Rating Summary:
    8 Buy, 18 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 24 | Down: 14 | New: 52
Trade HOLX Now!
Join SI Premium – FREE
Needham & Company analyst Mike Matson preformed a sum-of-the-parts analysis on Hologic (NASDAQ: HOLX), Carl Icahn's latest activist target.

"Given increased potential for moves by HOLX to increase shareholder value, we have performed a sum-of-parts analysis which shows that HOLX shares potentially could be worth up to $29," Matson said. "While an outright sale of HOLX is certainly possible, it is unlikely in our view. Some sort of break-up may make more sense and appears somewhat more likely to us than a sale. Given our analysis that shows that HOLX shares are undervalued and our belief that 2014 guidance is conservative, we reiterate our Buy rating."

Matson valued HOLX as five independent businesses (Gen-Probe plus four other businesses) using both EV/sales and EV/EBITDA multiples. They estimate that HOLX is worth around $21/share using EV/sales and around $29/share using EV/EBITDA. "Given HOLX's relatively high margins, we think that EV/EBITDA provides a more realistic valuation," Matson said.



The firm maintained a Buy rating and $26 on HOLX.

For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.

Shares of Hologic closed at $22.41 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Hedge Funds, Rumors

Related Entities

Carl Icahn, Needham & Company

Add Your Comment